Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults
Clinical trial NCT03239483 · COMPLETED
Trial details
- NCT number
- NCT03239483
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-26
- Primary completion
- 2018-09-20
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.